Evaluation of the flanking nucleotide sequences of sarcomeric hypertrophic cardiomyopathy substitution mutations

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 642, Issue 1-2, 2008, Pages 86-89

  Meurs, Kathryn M ^a   Mealey, Katrina L ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Deamination; Hypertrophic cardiomyopathy; Methylation; Mutation

Indexed keywords

ADENINE; ALPHA ACTIN; ALPHA TROPOMYOSIN; CYTOSINE; DINUCLEOTIDE; GUANINE; MYOSIN BINDING PROTEIN C; MYOSIN HEAVY CHAIN BETA; MYOSIN LIGHT CHAIN; THYMIDINE; TROPONIN I; TROPONIN T;

ALPHA TROPOMYOSIN GENE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CALCULATION; DEAMINATION; DNA FLANKING REGION; GENE; GENE MUTATION; HYPERTROPHIC CARDIOMYOPATHY; MYOFILAMENT; MYOSIN BINDING PROTEIN C GENE; MYOSIN HEAVY CHAIN BETA GENE; MYOSIN LIGHT CHAIN GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SARCOMERE; STATISTICAL ANALYSIS; TROPONIN I GENE; TROPONIN T GENE; DNA METHYLATION; GENETICS; HUMAN; MUTATION;

AMINO ACID SUBSTITUTION; BASE SEQUENCE; CARDIOMYOPATHY, HYPERTROPHIC; DNA METHYLATION; HUMANS; MUTATION; SARCOMERES;

EID: 49649083832     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2008.04.005     Document Type: Article

References (18)

1. Marian A.J., and Roberts R. The molecular genetic basis for hypertrophic cardiomyopathy. J. Mol. Cell Cardiol. 33 (2000) 655-670
2. Alcalai R., Seidman J.G., and Seidman C.E. Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. J. Cardiovasc. Electrophysiol. 19 (2007) 1-7
3. Bos J.M., Ommen S.R., and Ackerman M.J. Genetics of hypertrophic cardiomyopathy: one, two or more diseases?. Curr. Opin. Cardiol. 22 (2007) 193-199
4. Alders M., Jongbloed R., Deelen W., van den Wijngaard A., Doevendans P., Cate F.T., Regitz-Zagrosek V., Vosberg H.P., Van Langen I., Wilde A., Dooijes D., and Mannens M. The 2373insG mutation in the MYBPC3 gene is a founder mutation, which accounts for nearly one-fourth of the HCM cases in the Netherlands. Eur. Heart J. 24 (2003) 1848-1853
5. Erdmann J., Raible J., Maki-Abadi J., Hummel M., Hammann J., Wollnik B., Frantz E., Fleck E., Hetzer R., and Regitz-Zagrosek V. Spectrum of clinical phenotypes and gene variants in cardiac myosin-binding protein C mutation carriers with hypertrophic cardiomyopathy. J. Am. Coll. Cardiol. 38 (2001) 322-330
6. Watkins H., Thierfelder L., Anan R., Jarcho J., Matsumori A., McKenna W.J., Seidman J.G., and Seidman C.E. Independent origin of identical β cardiac myosin heavy chain mutations in hypertrophic cardiomyopathy. Am. J. Hum. Genet. 53 (1993) 1180-1185
7. Moolman J.C., De Lange W.J., Bruwer E.C.D., Brink P.A., and Corfield V.A. The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: a unique profile of both independent and founder events. Am. J. Hum. Genet. 65 (1999) 1308-1320
8. Krawczak M., Ball E.V., and Cooper D.N. Neighboring-nucleotide effects on the rates of germ-line single-base-pair substitution in human genes. Am. J. Hum. Genet. 63 (1998) 474-488
9. Antonarakis S.E., Krawczak M., and Cooper D.N. The nature and mechanisms of human gene mutation. In: Scriver C.R., and Sly W.S. (Eds). The Metabolic & Molecular Basis of Inherited Disease (2001), McGraw-Hill, New York 343-377
10. Arndt P.F., and Hwa T. Identification and measurement of neighbor-dependent nucleotide substutution processes. Bioinformatics 21 (2005) 2322-2328
11. Genomics of Cardiovascular Development, Adaptation, and Remodeling. NHLBI Program for Genomic Applications, Harvard Medical School (accessed October 2007).
12. Kent W.J., Sugnet C.W., Furey T.S., Roskin K.M., Pringle T.H., Zahler A.M., and Haussler D. The human genome browser at UCSC. Genome Res. 12 (2002) 996-1006. http://www.genome.org/cgi/content/abstract/12/6/996 http://www.genome.org/cgi/content/abstract/12/6/996
13. Cooper D.N., and Krawczak M. Single base pair substitutions. Human Gene Mutations (1999), BIOS Scientific Publishers Limited, Oxford pp. 109-162
14. Walsh C.P., and Xu G.L. Cytosine methylation and DNA repair. Curr. Top. Microbiol. Immunol. 301 (2006) 283-315
15. Feng Z., Hu W., Hu Y., and Tang M. Acrolein is a major cigarette-related lung cancer agent: preferential binding at p53 mutational hotspots and inhibition of DNA repair. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 15404-15409
16. Denissenko M.F., Pao A., Tang M., and Pfeifer G.P. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 274 (1996) 430-432
17. Pfeifer G.P., Denissenko M.F., Olivier M., Tretyakova N., Hecht S.S., and Hainaut P. Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers. Oncogene 21 (2002) 7435-7451
18. Chen J.X., Zheng Y., West M., and Tand M. Carcinogens preferentially bind at methylated CpG in the p53 mutational hotspots. Cancer Res. 58 (1998) 2070-2075